Rapt Therapeutics, Inc. (RAPT)

57.52 +22.42 (+63.87%) USD  |  NASDAQ  |  Jan 20, 11:44
More

Rapt Therapeutics Operating Income (Quarterly)

Operating Income (Quarterly) Chart

View Operating Income (Quarterly) for RAPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly) Range, Past 5 Years

View Operating Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly) Benchmarks

View Operating Income (Quarterly) Benchmarks
Start Trial
Replimune Group, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade